-
Taxonomy & unit
-
us-gaap: CNY and USD
-
Description
-
The cumulative amount of the reporting entity's undistributed earnings or deficit.
-
Summary
-
Gracell Biotechnologies Inc. quarterly Retained Earnings (Accumulated Deficit) history and growth rate from Q4 2020 to Q2 2023.
- Gracell Biotechnologies Inc. Retained Earnings (Accumulated Deficit) for the quarter ending June 30, 2023 was -$265M, a 34.4% decline year-over-year.
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Growth (%)